Olmesartan Medoxomil-d6

Modify Date: 2024-01-09 11:36:37

Olmesartan Medoxomil-d6 Structure
Olmesartan Medoxomil-d6 structure
Common Name Olmesartan Medoxomil-d6
CAS Number 1127298-67-2 Molecular Weight 564.62200
Density N/A Boiling Point N/A
Molecular Formula C29H24D6N6O6 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Olmesartan Medoxomil-d6


Olmesartan medoxomil-d6 (CS 866-d6) is the deuterium labeled Olmesartan medoxomil. Olmesartan medoxomil is a potent and selective angiotensin AT1 receptor inhibitor with IC50 of 66.2 μM[1][2].

 Names

Name Olmesartan Medoxomil-d6

 Olmesartan Medoxomil-d6 Biological Activity

Description Olmesartan medoxomil-d6 (CS 866-d6) is the deuterium labeled Olmesartan medoxomil. Olmesartan medoxomil is a potent and selective angiotensin AT1 receptor inhibitor with IC50 of 66.2 μM[1][2].
Related Catalog
In Vitro Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
References

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.

[2]. Senda A, et al. Effects of Angiotensin II Receptor Blockers on Metabolism of Arachidonic Acid via CYP2C8. Biol Pharm Bull. 2015;38(12):1975-9.

[3]. Shah S, et al. Simultaneous Quantitative Analysis of Olmesartan Medoxomil and Amlodipine Besylate in Plasma by High-performance Liquid Chromatography Technique. J Young Pharm. 2012 Apr;4(2):88-94.

[4]. Gu J, et al. Olmesartan Prevents Microalbuminuria in db/db Diabetic Mice Through Inhibition of Angiotensin II/p38/SIRT1-Induced Podocyte Apoptosis. Kidney Blood Press Res. 2016 Nov 21;41(6):848-864.

 Chemical & Physical Properties

Molecular Formula C29H24D6N6O6
Molecular Weight 564.62200
Exact Mass 564.26000
PSA 162.16000
LogP 4.17000